Biochemistry
-
Vanderbilt ranks 12th in annual survey of NIH funding; 2021 awards topped $445M
Vanderbilt University again ranked among the nation’s top research institutions receiving funding from the National Institutes of Health, according to the latest data compiled by the Blue Ridge Institute for Medical Research. Read MoreMar 31, 2022
-
Research Snapshot: Biochemical technique for finding small molecules discovered by Vanderbilt and University of Virginia researchers
A team including the Sanders lab developed a new methodology for finding small molecules associated with lipid rafts, an essential part of cell structure and regulation. Read MoreMar 28, 2022
-
Seven Vanderbilt faculty elected as AAAS fellows in 2021
Provost and Vice Chancellor for Academic Affairs C. Cybele Raver joins six others at Vanderbilt as 2021 fellows of the American Association for the Advancement of Science, the world’s largest general scientific society. Read MoreJan 26, 2022
-
Lopez lab develops computational tools to further understanding of complex biological systems
By Aaron Conley Systems biology and the Lopez lab The history of hermeneutics started with Aristotle—parts comprise the whole. To understand the whole, we need to understand the parts. And to understand the parts, we need to understand them in the context of the whole. Carlos F. Lopez, associate… Read MoreJan 20, 2022
-
Watch: ‘The Science of Flavor’ conversation explores how flavor science impacts the restaurant industry
Join taste experts, scientists and a Nashville chef to learn about the science behind flavor in a virtual event on Monday, Jan. 31, at noon CT. Read MoreJan 18, 2022
-
Watch: Lab-to-Table Conversations: “The Science of Beer” featuring biochemistry faculty and beer science alumni
Vanderbilt alumni and the founders of Jackalope Brewing Co. and Yazoo Brewing Co. will join Vanderbilt researchers for a Dec. 16 virtual discussion about beer and fermentation science. Read MoreNov 30, 2021
-
Professor makes Vanderbilt-discovered cancer targeting molecule freely available to researchers through collaboration with Boehringer Ingelheim
Stephen Fesik’s discovery of a cancer-targeting molecule has been made freely accessible through opnMe for global researchers to advance research into cancer therapeutics. Read MoreNov 15, 2021
-
Global Vanderbilt: Carlos Lopez: “It’s beyond you’re welcome here, this is the place where you belong.”
Carlos Lopez, associate professor of biochemistry and biomedical informatics, describes how international faculty belong at Vanderbilt. Read MoreOct 21, 2021
-
Cohen Innovation Fund Awards Announced Supporting Two High-Risk, High-Reward Projects
Houra Merrikh, professor of biochemistry, and Teru Nakagawa, associate professor of molecular physiology and biophysics, have both been selected to receive one-year research awards from the Stanley Cohen Innovation Fund. The awards will support groundbreaking and paradigm-shifting research. Read MoreSep 28, 2021
-
Research Snapshot: Development of a new framework and tool for multi-drug synergy and combination
MuSyC is a technique to help researchers devise new combinations of drugs. An open-source analysis tool, it holds the promise speed such discoveries around the world. Read MoreAug 24, 2021
-
Research Snapshot: Researchers derive new cancer therapies to decrease the risk of heart damage
Following decades of worldwide research standstills on cancer drug improvement, Steven Townsend and his team of researchers synthesize cancer therapeutics that bypass toxicity aimed at heart health. Est. reading time: 2.5 minutes. Read MoreJul 29, 2021
-
Merrikh named finalist for Blavatnik National Award for Young Scientists for second year
For the second year in a row, Professor of Biochemistry Houra Merrikh has been named a finalist for the 2021 Blavatnik National Awards for Young Scientists in the life sciences category for her discovery of a potential solution to prevent the evolution of antimicrobial resistance and, in some cases, even reverse existing resistance. Read MoreJun 17, 2021
-
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Read MoreFeb 25, 2021
-
SARS-CoV-2 protein blocks an essential step in host gene expression, new discovery finds
Vanderbilt biochemist Yi Ren is part of a team that has identified a new behavior of a SARS-CoV-2 protein and discovered that interfering with its function can block virus replication in host cells. This opens up the potential for new therapeutic targets for COVID-19. Read MoreFeb 17, 2021
-
Bruce Carter joins CMT Research Foundation scientific advisory board
Bruce Carter, professor of biochemistry and an associate director of the Vanderbilt Brain Institute, has been appointed to the scientific advisory board of the CMT Research Foundation, which shapes research directions and therapeutic development of Charcot-Marie-Tooth disease. Read MoreFeb 12, 2021
-
Scientists discuss inclusion and equity in biomedical research at virtual event
Biomedical researchers across Vanderbilt University will convene to discuss the history and impact of Black biomedical scientists on Monday, Feb. 15, at noon CT. Read MoreFeb 9, 2021
-
Cortez named interim chair in the Department of Biochemistry; York named Impossible Foods chief science officer
David Cortez, Richard N. Armstrong Chair for Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1. This follows the departure of John York, who was recently named chief science officer of California-based food technology startup Impossible Foods. Read MoreDec 8, 2020
-
Kudos: Read about faculty, staff and student awards, appointments and achievements
Read about the latest faculty, staff and student awards, appointments and achievements. Read MoreNov 24, 2020
-
Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease
Further research by biochemistry professors Charles Sanders and Bruce Carter into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves, will be funded by Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt’s innovative life science research. Read MoreNov 17, 2020
-
Vanderbilt researchers work to build a molecular Trojan horse to battle COVID-19
Vanderbilt biochemists figure out how the little-understood Envelope protein helps SARS-CoV-2 function and how to disrupt the endogenously creative virus. Read MoreNov 17, 2020